Log in to save to my catalogue

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer...

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b52435dfcf7a4d5aa13e0d196ad259a1

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model

About this item

Full title

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2019-03, Vol.10 (1), p.1365-1365, Article 1365

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial surface receptor genetically linked to the risk for Alzheimer’s disease (AD). A proteolytic product, soluble TREM2 (sTREM2), is abundant in the cerebrospinal fluid and its levels positively correlate with neuronal injury markers. To gain insights into the pathological roles of...

Alternative Titles

Full title

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b52435dfcf7a4d5aa13e0d196ad259a1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b52435dfcf7a4d5aa13e0d196ad259a1

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-019-09118-9

How to access this item